2-(1H-1,2,4-Triazol-1-yl)-N-{[3-(trifluoromethyl)phenyl]methyl}acetamide

Catalog No. :
ACGDEQ704
CAS No. :
672950-16-2
Molecular Formula :
C12H11F3N4O
Molecular Weight :
284.24

IUPAC Name:2-(1H-1,2,4-triazol-1-yl)-N-(3-(trifluoromethyl)benzyl)acetamide

2-(1H-1,2,4-Triazol-1-yl)-N-{[3-(trifluoromethyl)phenyl]methyl}acetamide structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
1g90%$284.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name2-(1H-1,2,4-Triazol-1-yl)-N-{[3-(trifluoromethyl)phenyl]methyl}acetamide
IUPAC Name2-(1H-1,2,4-triazol-1-yl)-N-(3-(trifluoromethyl)benzyl)acetamide
MDL No.MFCD02186922
Molecular FormulaC12H11F3N4O
Molecular Weight284.24
SMILESO=C(NCC1=CC=CC(C(F)(F)F)=C1)CN2N=CN=C2
InChI KeyHCSXLIGUGJPPAL-UHFFFAOYSA-N
Synonym2-(1H-1,2,4-TRIAZOL-1-YL)-N-[3-(TRIFLUOROMETHYL)BENZYL]ACETAMIDE;2-(1H-1,2,4-triazol-1-yl)-N-{[3-(trifluoromethyl)phenyl]methyl}acetamide;1H-1,2,4-Triazole-1-acetamide, N-[[3-(trifluoromethyl)phenyl]methyl]-
CAS No.672950-16-2

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P280-P301+P312-P302+P352-P305+P351+P338

Synthetic Route by SureRoute

1. ACGDEQ704 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACKPCZ073 route compound structure diagram
    ACKPCZ07328711-29-7 In Stock
  4. Then
  5. ACGDEQ704 route product structure diagram
    ACGDEQ704672950-16-2
Inquiry

2. ACGDEQ704 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACBSYZ572 route compound structure diagram
    ACBSYZ57241253-21-8 In Stock
  4. Then
  5. ACGDEQ704 route product structure diagram
    ACGDEQ704672950-16-2
Inquiry

Comments (0)